Another recent NGS study involving 213 PD patients revealed three novel VPS35 variations (i.e., p.P316S, p.Y507F, and p.E787K), leading to changes in coded amino acids potentially contributing to PD pathogenesis. This evidence concerns the gene VPS35 and Parkinson disease.